Plant non-starch polysaccharides that inhibit key enzymes linked to type 2 diabetes mellitus

Annals of the New York Academy of Sciences

Volumn 1401, Issue 1, 2017, Pages 28-36

  Liu, Dan ^a   Gao, He ^a   Tang, Wei ^a   Nie, Shaoping ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

inhibition activity; key enzymes; plant non starch polysaccharides; type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE; AMYLASE; DIPEPTIDYL PEPTIDASE IV; ENZYME; POLYSACCHARIDE; TRIACYLGLYCEROL LIPASE; ENZYME INHIBITOR; PLANT EXTRACT;

ENZYME INHIBITION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DIABETES MELLITUS, TYPE 2; ENZYMOLOGY; METABOLISM;

ALPHA-AMYLASES; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; ENZYME INHIBITORS; HUMANS; LIPASE; PLANT EXTRACTS; POLYSACCHARIDES;

EID: 85030615159     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13430     Document Type: Review

References (66)

1. Wu, J., S. Shi, H. Wang, et al. 2016. Mechanisms underlying the effect of polysaccharides in the treatment of type 2 diabetes: a review. Carbohydr. Polym. 144: 474–494.
2. Wang, P.-C., S. Zhao, B.-Y. Yang, et al. 2016. Anti-diabetic polysaccharides from natural sources: a review. Carbohydr. Polym. 148: 86–97.
3. Perk, J., G. De Backer, H. Gohlke, et al. 2012. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur. Heart J. 33: 1635–1701.
4. You, Q., F. Chen, X. Wang, et al. 2012. Anti-diabetic activities of phenolic compounds in muscadine against alpha-glucosidase and pancreatic lipase. LWT – Food Sci. Technol. 46: 164–168.
5. Kahn, S.E., R.L. Hull & K.M. Utzschneider. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840–846.
6. Meloni, A.R., M.B. DeYoung, C. Lowe, et al. 2013. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence. Diabetes Obes. Metab. 15: 15–27.
7. Chang, J.-H., C.-F. Tseng & J.-Y. Wang. 2007. Hypoglycemia-induced myocardial infarction: an unusual adverse effect of sulfonylureas. Int. J. Cardiol. 115: 414–416.
8. Chang, C. & T. Schiano. 2007. Review article: drug hepatotoxicity. Aliment. Pharmacol. Ther. 25: 1135–1151.
9. Van De Laar, F.A., P.L. Lucassen, R.P. Akkermans, et al. 2005. α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 28: 154–163.
10. Gulliford, M. & R. Latinovic. 2004. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study. Diabetes Metab. Res. Rev. 20: 239–245.
11. Kumar, V., A.K. Sinha, H.P.S. Makkar, et al. 2012. Dietary roles of non-starch polysachharides in human nutrition: a review. Crit. Rev. Food Sci. Nutr. 52: 899–935.
12. Butler, G.W. & R.W. Bailey. 1973. Chemistry and Biochemistry of Herbage. New York: Academic Press.
13. Davidson, M.H. & A. McDonald. 1998. Fiber: forms and functions. Nutr. Res. 18: 617–624.
14. Xu, E., Z. Wu, J. Long, et al. 2015. Effect of thermostable α-amylase addition on the physicochemical properties, free/bound phenolics and antioxidant capacities of extruded hulled and whole rice. Food Bioprocess Tech. 8: 1958–1973.
15. BelHadj, S., O. Hentati, A. Elfeki, et al. 2013. Inhibitory activities of Ulva lactuca polysaccharides on digestive enzymes related to diabetes and obesity. Arch. Physiol. Biochem. 119: 81–87.
16. Li, W., H. Zheng, J. Bukuru, et al. 2004. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 92: 1–21.
17. Zhang, S. & X.-Z. Li. 2015. Inhibition of α-glucosidase by polysaccharides from the fruit hull of Camellia oleifera Abel. Carbohydr. Polym. 115: 38–43.
18. Zhang, Z., F. Kong, H. Ni, et al. 2016. Structural characterization, α-glucosidase inhibitory and DPPH scavenging activities of polysaccharides from guava. Carbohydr. Polym. 144: 106–114.
19. Lordan, S., T.J. Smyth, A. Soler-Vila, et al. 2013. The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts. Food Chem. 141: 2170–2176.
20. Machius, M., G. Wiegand & R. Huber. 1995. Crystal structure of calcium-depleted Bacillus licheniformis α-amylase at 2.2 Å resolution. J. Mol. Biol. 246: 545–559.
21. Reddy, N., A. Nimmagadda & K.S. Rao. 2003. An overview of the microbial α-amylase family. Afr. J. Biotechnol. 2: 645–648.
22. Apostolidis, E., Y.-I. Kwon & K. Shetty. 2007. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov. Food Sci. Emerg. Technol. 8: 46–54.
23. Nampoothiri, S.V., A. Prathapan, O.L. Cherian, et al. 2011. In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem. Toxicol. 49: 125–131.
24. Chen, S., H. Chen, J. Tian, et al. 2013. Chemical modification, antioxidant and α-amylase inhibitory activities of corn silk polysaccharides. Carbohydr. Polym. 98: 428–437.
25. Chen, C., L.-J. You, A.M. Abbasi, et al. 2015. Optimization for ultrasound extraction of polysaccharides from mulberry fruits with antioxidant and hyperglycemic activity in vitro. Carbohydr. Polym. 130: 122–132.
26. Dhital, S., M.J. Gidley & F.J. Warren. 2015. Inhibition of α-amylase activity by cellulose: kinetic analysis and nutritional implications. Carbohydr. Polym. 123: 305–312.
27. Hu, J.-L., S.-P. Nie, C. Li, et al. 2013. In vitro effects of a novel polysaccharide from the seeds of Plantago asiatica L. on intestinal function. Int. J. Biol. Macromol. 54: 264–269.
28. Liu, G., S. Xu & L. Chen. 2012. Chemical composition and bioactivities of a water-soluble polysaccharide from the endodermis of shaddock. Int. J. Biol. Macromol. 51: 763–766.
29. Kumar, T.V., S. Lakshmanasenthil, D. Geetharamani, et al. 2015. Fucoidan–A α-d-glucosidase inhibitor from Sargassum wightii with relevance to type 2 diabetes mellitus therapy. Int. J. Biol. Macromol. 72: 1044–1047.
30. Espinal-Ruiz, M., F. Parada-Alfonso, L.-P. Restrepo-Sánchez, et al. 2014. Inhibition of digestive enzyme activities by pectic polysaccharides in model solutions. Bioactive Carbohydr. Diet. Fibre 4: 27–38.
31. Kim, K.-T., L.-E. Rioux & S.L. Turgeon. 2015. Molecular weight and sulfate content modulate the inhibition of α-amylase by fucoidan relevant for type 2 diabetes management. PharmaNutrition 3: 108–114.
32. Huang, Y.-L., C.-J. Chow & Y.-H. Tsai. 2012. Composition, characteristics, and in-vitro physiological effects of the water-soluble polysaccharides from Cassia seed. Food Chem. 134: 1967–1972.
33. Selle, P., V. Ravindran, A. Caldwell, et al. 2000. Phytate and phytase: consequences for protein utilisation. Nutr. Res. Rev. 13: 255–278.
34. Demirkan, E., S. Dincbas, N. Sevinc, et al. 2011. Immobilization of B. amyloliquefaciens α-amylase and comparison of some of its enzymatic properties with the free form. Rom. Biotechnol. Lett. 16: 6690–6701.
35. Silanikove, N., A. Perevolotsky & F.D. Provenza. 2001. Use of tannin-binding chemicals to assay for tannins and their negative postingestive effects in ruminants. Anim. Feed Sci. Technol. 91: 69–81.
36. Chiba, S. 1997. Molecular mechanism in α-glucosidase and glucoamylase. Biosci. Biotechnol. Biochem. 61: 1233–1239.
37. Hermans, M., M. Kroos, J. Van Beeumen, et al. 1991. Human lysosomal alpha-glucosidase. Characterization of the catalytic site. J. Biol. Chem. 266: 13507–13512.
38. Gray, G.M. 1975. Carbohydrate digestion and absorption: role of the small intestine. N. Engl. J. Med. 292: 1225–1230.
39. Ademiluyi, A.O. & G. Oboh. 2013. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp. Toxicol. Pathol. 65: 305–309.
40. Kim, K.-T., L.-E. Rioux & S.L. Turgeon. 2014. Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum. Phytochemistry 98: 27–33.
41. Qian, J.-Y., Y.-Y. Bai, J. Tang, et al. 2015. Antioxidation and α-glucosidase inhibitory activities of barley polysaccharides modified with sulfation. LWT – Food Sci. Technol. 64: 104–111.
42. Cho, M., J.H. Han & S. You. 2011. Inhibitory effects of fucan sulfates on enzymatic hydrolysis of starch. LWT – Food Sci. Technol. 44: 1164–1171.
43. De Melo, E.B., A. Gomes & I. Carvalho. 2006. α-and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 62: 10277–10302.
44. Braun, C., G.D. Brayer & S.G. Withers. 1995. Mechanism-based inhibition of yeast α-glucosidase and human pancreatic α-amylase by a new class of inhibitors 2-deoxy-2, 2-difluoro-α-glycosides. J. Biol. Chem. 270: 26778–26781.
45. Mohan, S. & B.M. Pinto. 2007. Zwitterionic glycosidase inhibitors: salacinol and related analogues. Carbohydr. Res. 342: 1551–1580.
46. Schmidt, D.D., W. Frommer, B. Junge, et al. 1977. α-Glucosidase inhibitors. Naturwissenschaften 64: 535–536.
47. Winkler, F.K., A. D'Arcy & W. Hunziker. 1990. Structure of human pancreatic lipase. Nature 343: 771−774.
48. Mead, J.R., S.A. Irvine & D.P. Ramji. 2002. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80: 753–769.
49. Freeman, K.S., T.T. Tang, R.D. Shah, et al. 2000. Activity and stability of lipase in AOT reversed micelles with bile salt cosurfactant. J. Phys. Chem. B 104: 9312–9316.
50. Gurung, N., S. Ray, S. Bose, et al. 2013. A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. Biomed. Res. Int. 2013: 1–18.
51. Kim, H.R., C.T. Hou, K.T. Lee, et al. 2010. Enzymatic synthesis of structured lipids using a novel cold-active lipase from Pichia lynferdii NRRL Y-7723. Food Chem. 122: 846–849.
52. Tsujita, T., H. Takaichi, T. Takaku, et al. 2007. Inhibition of lipase activities by basic polysaccharide. J. Lipid Res. 48: 358–365.
53. Balasubramaniam, V., S. Mustar, N. Mustafa Khalid, et al. 2013. Inhibitory activities of three Malaysian edible seaweeds on lipase and α-amylase. J. Appl. Phycol. 25: 1405–1412.
54. Thoma, R., B. Löffler, M. Stihle, et al. 2003. Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11: 947–959.
55. Bonin, A., J. Hühn & B. Fleischer. 1998. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161: 43–53.
56. Holz, G.G., W.M. Kühtreiber & J.F. Habener. 1993. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7–37). Nature 361: 362–365.
57. Meier, J.J. 2012. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8: 728–742.
58. Deacon, C.F. 2011. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review. Diabetes Obes. Metab. 13: 7–18.
59. Hanefeld, M., P. Brunetti, G.H. Schernthaner, et al. 2004. One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes. Diabetes Care 27: 141–147.
60. Jung, U.J., M.-K. Lee, K.-S. Jeong, et al. 2004. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 134: 2499–2503.
61. Proost, P., S. Struyf, D. Schols, et al. 1999. Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J. Biol. Chem. 274: 3988–3993.
62. Hinke, S.A., J.A. Pospisilik, H.-U. Demuth, et al. 2000. Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J. Biol. Chem. 275: 3827–3834.
63. Mentlein, R. 1999. Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides. Regul. Pept. 85: 9–24.
64. Tarling, C.A., K. Woods, R. Zhang, et al. 2008. The search for novel human pancreatic α-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts. ChemBioChem 9: 433–438.
65. Iwata, E., H. Hotta & M. Goto. 2012. Hypolipidemic and bifidogenic potentials in the dietary fiber prepared from mikan (Japanese mandarin orange: Citrus unshiu) albedo. J. Nutr. Sci. Vitaminol. 58: 175–180.
66. Edashige, Y., N. Murakami & T. Tsujita. 2008. Inhibitory effect of pectin from the segment membrane of citrus fruits on lipase activity. J. Nutr. Sci. Vitaminol. 54: 409–415.